Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-Esophageal(GE) Junction Cancer”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Study completedNCT00680901
What this trial is testing

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
Novartis Pharmaceuticals 545
Testing effectiveness (Phase 2)Ended earlyNCT01774851
What this trial is testing

MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach

Who this might be right for
HER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more
Merrimack Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT00526669
What this trial is testing

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
GlaxoSmithKline 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03448835
What this trial is testing

Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)

Who this might be right for
Stomach CancerGastro Esophageal Junction Cancer
The Netherlands Cancer Institute 20
Very early researchStudy completedNCT00215514
What this trial is testing

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Stomach CancerGastric CancerGastro-esophageal Junction Cancer
Dana-Farber Cancer Institute 25
Not applicableWithdrawnNCT01031056
What this trial is testing

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Who this might be right for
Gastrointestinal NeoplasmsGynecologic CancersGynecologic Cancers Cervical Cancer+11 more
Stanford University
Not applicableLooking for participantsNCT01048281
What this trial is testing

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Who this might be right for
Stomach CancerGastro-Esophageal(GE) Junction CancerGastric (Stomach) Cancer+2 more
Stanford University 100
Testing effectiveness (Phase 2)Study completedNCT00165191
What this trial is testing

Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

Who this might be right for
Adenocarcinoma of StomachAdenocarcinoma of GE JunctionAdenocarcinoma of Esophagus
Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT00165464
What this trial is testing

Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric CancerGE Junction Cancer
Dana-Farber Cancer Institute 54
Testing effectiveness (Phase 2)Study completedNCT00952497
What this trial is testing

Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
ACT Biotech, Inc 48
Early research (Phase 1)Study completedNCT01183559
What this trial is testing

A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery

Who this might be right for
Cancer of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionCancer of the Stomach
Fox Chase Cancer Center 9
Not applicableStudy completedNCT02538562
What this trial is testing

Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Hoffmann-La Roche 1,695